Veriheal
MAY 18, 2023
Chronic pain —a condition that affects 50.2 Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronic pain relief have been somewhat hazy…up until now. New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers.
TheAnswerPage
MAY 15, 2023
There is moderate evidence that marijuana or cannabinoids are effective for improving short-term sleep outcomes in individuals with sleep disturbance associated with obstructive sleep apnea syndrome, fibromyalgia, chronic pain, and multiple sclerosis. Kumar RN, Chambers WA, Pertwee RG. Anaesthesia.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TheAnswerPage
APRIL 28, 2021
There is moderate evidence that marijuana or cannabinoids are effective for improving short-term sleep outcomes in individuals with sleep disturbance associated with obstructive sleep apnea syndrome, fibromyalgia, chronic pain, and multiple sclerosis. 2001; 56: 1059-1068. Kumar RN, Chambers WA, Pertwee RG. Anaesthesia.
Veriheal
AUGUST 7, 2022
All of the study subjects were enrolled in the nation’s federally legal medical cannabis program, which was launched by Health Canada back in 2001. Examples include chronic pain, chemotherapy-related nausea and vomiting, anxiety, depression, and muscle inflammation. As of 2020, the market was worth CAD $2.6
Cannabis Law Report
APRIL 1, 2022
Not only is it the second British cannabis company to go public in as many weeks , but Celadon is the second homegrown cannabis company ever to list on AIM, following GW Pharmaceuticals in 2001. Admission . The newly formed entity now has 61.7m ordinary shares in issue, giving it a market capitalisation at admission of £97.4
Cannabis Law Report
MAY 14, 2019
Escalating numbers of people in the UK are being given highly addictive painkillers for chronic pain in spite of evidence pointing that they become ineffective after just a few days. It recommended moving cannabis from Schedule B to Schedule 2 of the Misuse of Drugs Regulations 2001, which means it can be prescribed.
CannaTech
SEPTEMBER 16, 2018
Canada has been at the forefront of shaping much of the rhetoric surrounding cannabis since 2001. But this gap restricts patient access to a medicine that can offer relief to a long list of conditions including chronic pain, seizures attributed to epilepsy, as well as mood disorders such as anxiety and depression.
Expert insights. Personalized for you.
98 
Let's personalize your content